NewAmsterdam Pharma Company N.V.
NAMS
$36.47
-$3.98-9.84%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 739.16M | 808.48M | 834.19M | 422.73M | 430.71M |
| Total Receivables | 19.75M | 1.61M | 21.31M | 5.15M | 5.41M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.94M | 7.21M | 7.92M | 10.00M | 9.24M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 769.85M | 817.30M | 863.41M | 437.87M | 445.35M |
|
|
|||||
| Total Current Assets | 769.85M | 817.30M | 863.41M | 437.87M | 445.35M |
| Net Property, Plant & Equipment | 620.00K | 607.00K | 673.00K | 724.00K | 788.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 470.00K | 502.00K | 534.00K | 593.00K | 542.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | 8.00K |
| Total Assets | 815.11M | 818.41M | 864.62M | 439.19M | 446.69M |
|
|
|||||
| Total Accounts Payable | 5.90M | 6.09M | 4.74M | 7.04M | 5.28M |
| Total Accrued Expenses | 9.46M | 8.02M | 13.61M | 10.58M | 10.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 225.00K | 252.00K | 246.00K | 240.00K | 234.00K |
| Total Finance Division Other Current Liabilities | 20.93M | 26.55M | 88.32M | 23.40M | 29.60M |
| Total Other Current Liabilities | 20.93M | 26.55M | 88.32M | 23.40M | 29.60M |
| Total Current Liabilities | 36.51M | 40.91M | 106.92M | 41.26M | 45.31M |
|
|
|||||
| Total Current Liabilities | 36.51M | 40.91M | 106.92M | 41.26M | 45.31M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 103.00K | 137.00K | 202.00K | 266.00K | 328.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 18.81M | 13.62M |
| Total Liabilities | 36.62M | 41.05M | 107.12M | 60.33M | 59.25M |
|
|
|||||
| Common Stock & APIC | 1.39B | 1.37B | 1.31B | 840.83M | 832.76M |
| Retained Earnings | -615.46M | -598.10M | -558.57M | -466.39M | -449.75M |
| Treasury Stock & Other | 4.33M | 4.43M | 4.47M | 4.42M | 4.42M |
| Total Common Equity | 778.50M | 777.36M | 757.50M | 378.86M | 387.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 778.50M | 777.36M | 757.50M | 378.86M | 387.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 778.50M | 777.36M | 757.50M | 378.86M | 387.44M |
|
|
|||||